Results reproduce PrecisionLife’s previously identified long COVID genetic associations to provide compelling evidence for new precision diagnostics and treatments
In just a matter of weeks since the inauguration of Donald Trump as the 47th president of the United States of America (US), he has already signed multiple executive orders, some of which could have a significant impact, not just on the US tax landscape, but on global tax policy.
Of course, many of Trump’s policy objectives were well documented through the presidential campaign, although tax policy certainly took a back seat this time around when compared to the issues debated in the run up to the 2016 US election, when Trump first took the Oval Office.
MediWales will be holding their annual all-Wales NHS Connects Conference on the 17th of June at the All Nations Centre in Cardiff.
NHS colleagues from across Wales, local companies and the wider industry sector will join to share clinical innovation in practice to improve patient outcomes.
The event includes presentations, workshops, exhibitions and networking.
The aims of the conference are to:
A round-up of the One Nucleus Annual Award ambitions and shortlisted entries ahead of the celebratory dinner on 27 March 2025 in London.
By Tony Jones, CEO, One Nucleus
MediWales are holding their annual BioWales in London conference on the 12th of March 2025.
This conference will bring together industry and health to showcase Welsh innovation in life sciences, including MedTech, diagnostics and NHS collaborations. Delegates will have the chance to discuss the latest breakthroughs and advancements in these fields while exploring new opportunities for growth and collaboration.
Parameters are generally used in patent claims to define subject matter which cannot be expressed in terms of structural features. They can be the most appropriate way to ensure that a claim scope effectively covers an inventor’s contribution. The use of parameters is common for inventions in the chemical field but they can find applicability in a wide variety of technological areas.
12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.
The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand Interaction Fingerprints (PLIF).
Science, research and innovation are core disciplines that will undoubtedly help the human race address many of the key challenges it faces. Whether it is dealing with climate change, ending world hunger or living healthier and longer lives, we need to create environments that will enable scientists and researchers to make ground-breaking discoveries to be made. That means building a support network to work alongside them made up of individuals with other skills and disciplines.
PrecisionLife has been awarded a €2.5m non-dilutive grant by the European Innovation Council (EIC) for its TRANSCEND project, to more rapidly and accurately triage and treat patients with endometriosis. The project is based on PrecisionLife’s unique insights into the biological mechanisms underpinning this complex chronic disease. It will develop and clinically validate a rapid and non-invasive precision medicine test to evaluate a patient’s risk of endometriosis and the mechanisms underpinning their disease.
🚀 Ready to join a team that’s Revolutionizing Science and Redefining the Workplace?
We’re hiring: Senior Scientist, Protein Sciences